IL-18 Receptor Complex: Potential Drug & Biomarker Targets (P42105)

Target Name: Interleukin-18 Receptor Complex

NCBI ID: P42105

Interleukin-18 Receptor Complex

Other Name(s): IL-18 Receptor complex | IL-18R

IL-18 Receptor Complex: Potential Drug & Biomarker Targets

The Interleukin-18 Receptor Complex (IL-18 Receptor complex) is a protein complex that plays a crucial role in the regulation of immune and inflammatory responses.IL-18 Receptor complex is composed of several proteins including IL-18 receptor alpha chain (IL -18RA), IL-18 receptor beta chain (IL-18RB), and IL-18 receptor gamma chain (IL-18RG). The IL-18RA and IL-18RB proteins are involved in the intracellular signaling cascade, while IL-18RG is involved in the in vitro signaling.

The IL-18 Receptor complex is involved in the regulation of various immune and inflammatory responses, including inflammation, pain, and survival. The IL-18 Receptor complex is also involved in the regulation of cell survival, angiogenesis, and inflammation.

IL-18 Receptor complex is a potential drug target in the treatment of various diseases, including cancer, autoimmune diseases, and chronic obstructive pulmonary disease (COPD).

Drugs that target the IL-18 Receptor complex have been shown to have efficacy in treating various diseases, including cancer, autoimmune diseases, and COPD. For example, a drug called ALZ-801 is currently being investigated for its potential to treat cancer by targeting the IL-18 Receptor complex.

In addition to its potential as a drug target, the IL-18 Receptor complex is also a potential biomarker for various diseases. The IL-18RA and IL-18RB proteins are involved in the intracellular signaling cascade, which makes them potential indicators of inflammation and inflammation immune responses. Therefore, measuring the levels of these proteins can be used as a biomarker for various diseases, including cancer, autoimmune diseases, and COPD.

In conclusion, the IL-18 Receptor complex is a protein complex that plays a crucial role in the regulation of immune and inflammatory responses. It is a potential drug target and biomarker for various diseases, including cancer, autoimmune diseases, and COPD. Further research is needed to fully understand the role of the IL-18 Receptor complex in the regulation of immune and inflammatory responses and its potential as a drug and biomarker.

Protein Name: Interleukin-18 Receptor Complex

The "Interleukin-18 Receptor Complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Interleukin-18 Receptor Complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets